• Publications
  • Influence
Clinical epidemiology of cardiovascular disease in chronic renal disease.
  • 3,204
  • 91
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.
End-stage renal disease (ESRD) patients have a high cardiovascular mortality rate. Precise estimates of the prevalence, risk factors and prognosis of different manifestations of cardiac disease areExpand
  • 1,195
  • 41
Epidemiology of cardiovascular disease in chronic renal disease.
The risk of cardiovascular disease in patients with chronic renal disease appears to be far greater than in the general population. For example, among patients treated by hemodialysis or peritonealExpand
  • 1,174
  • 39
Comparative Genomics Identifies a Flagellar and Basal Body Proteome that Includes the BBS5 Human Disease Gene
Cilia and flagella are microtubule-based structures nucleated by modified centrioles termed basal bodies. These biochemically complex organelles have more than 250 and 150 polypeptides, respectively.Expand
  • 723
  • 29
The clinical epidemiology of cardiac disease in chronic renal failure.
The annual mortality from cardiovascular disease in dialysis patients is substantially higher than in the general population ([Figure 1][1]) ([1][2]). The 5-yr survival of men >64 yr old startingExpand
  • 590
  • 27
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome.
To determine the interfamilial and intrafamilial variation in the expression of the Bardet-Biedl syndrome (a form of Laurence-Moon-Biedl syndrome), we looked for the five recognized features of theExpand
  • 461
  • 27
Outcome and risk factors for left ventricular disorders in chronic uraemia.
BACKGROUND Left ventricular disease occurs frequently in dialysis patients. It may be manifest as concentric LV hypertrophy, LV dilatation with or without LV hypertrophy, or systolic dysfunction.Expand
  • 597
  • 21
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease.
It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident hemodialysis patients without symptomatic heart disease and left ventricular dilation. In this randomized,Expand
  • 347
  • 21
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
Autosomal-dominant arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) causes sudden cardiac death and is characterized by clinical and genetic heterogeneity. Fifteen unrelated ARVCExpand
  • 372
  • 21